296 related articles for article (PubMed ID: 1968358)
21. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
22. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
[TBL] [Abstract][Full Text] [Related]
23. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
[TBL] [Abstract][Full Text] [Related]
24. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
25. Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B.
Fu LW; Pan QC; Liang YJ; Huang HB
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):435-9. PubMed ID: 10678092
[TBL] [Abstract][Full Text] [Related]
26. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
27. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts.
Shudo N; Mizoguchi T; Kiyosue T; Arita M; Yoshimura A; Seto K; Sakoda R; Akiyama S
Cancer Res; 1990 May; 50(10):3055-61. PubMed ID: 1970752
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
Schwartz GK; Arkin H; Holland JF; Ohnuma T
Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824
[TBL] [Abstract][Full Text] [Related]
29. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
Qian XD; Beck WT
Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551
[TBL] [Abstract][Full Text] [Related]
30. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
Coley HM; Twentyman PR; Workman P
Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
[TBL] [Abstract][Full Text] [Related]
31. Selection of a new multidrug resistant cell line from Friend leukemia cells by short and cyclic exposures to high concentrations of daunorubicin.
Abbadessa V; Tolomeo M; Luparello M; Perricone R; Cajozzo A; Dusonchet L; Candiloro V; Crosta L; Rausa L
Haematologica; 1992; 77(2):137-41. PubMed ID: 1356894
[TBL] [Abstract][Full Text] [Related]
32. Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their properties.
Iwahashi T; Okochi E; Ono K; Sugawara I; Tsuruo T; Mori S
Anticancer Res; 1991; 11(3):1309-12. PubMed ID: 1679619
[TBL] [Abstract][Full Text] [Related]
33. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
Lelong IH; Guzikowski AP; Haugland RP; Pastan I; Gottesman MM; Willingham MC
Mol Pharmacol; 1991 Oct; 40(4):490-4. PubMed ID: 1681415
[TBL] [Abstract][Full Text] [Related]
34. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
35. Terfenadine (Seldane): a new drug for restoring sensitivity to multidrug resistant cancer cells.
Hait WN; Gesmonde JF; Murren JR; Yang JM; Chen HX; Reiss M
Biochem Pharmacol; 1993 Jan; 45(2):401-6. PubMed ID: 8094615
[TBL] [Abstract][Full Text] [Related]
36. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
Ford JM; Yang JM; Hait WN
Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
Hait WN; Choudhury S; Srimatkandada S; Murren JR
J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047
[TBL] [Abstract][Full Text] [Related]
38. Molecular modeling study of the multidrug resistance modifiers cis- and trans-flupentixol.
Wiese M; Pajeva IK
Pharmazie; 1997 Sep; 52(9):679-85. PubMed ID: 9347570
[TBL] [Abstract][Full Text] [Related]
39. A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells.
Yeh GC; Lopaczynska J; Poore CM; Phang JM
Cancer Res; 1992 Dec; 52(23):6692-5. PubMed ID: 1358437
[TBL] [Abstract][Full Text] [Related]
40. N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells.
Lothstein L; Wright HM; Sweatman TW; Israel M
Oncol Res; 1992; 4(8-9):341-7. PubMed ID: 1362503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]